Page 29 - Read Online
P. 29

Sawabata et al.                                                                                                                                                               Pulmonary wedge resection for NSCLC

               accompanying wedge resection for clinical stage IA lung cancer†. Eur   non-small cell lung cancer: an Italian multicenter observational study.
               J Cardiothorac Surg 2017;51:511-7.                Lung Cancer 2014;84:248-53.
           37.  Kodama K, Doi O, Higashiyama  M, Yokouchi H. Intentional   51.  Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K,
               limited resection for selected patients with T1 N0 M0 non-small-cell   Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A,
               lung cancer: a single-institution  study.  J Thorac Cardiovasc Surg   Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R,
               1997;114:347-53.                                  Itami J, Araki T. Stereotactic body radiotherapy (SBRT) for operable
           38.  Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional   stage  I non-small-cell  lung  cancer:  can SBRT be  comparable  to
               limited  pulmonary resection  for peripheral  T1 N0 M0 small-sized   surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
               lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8.  52.  Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof
           39.  Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota   EM, Van Vulpen M, Schramel FM. Clinical outcomes in early-stage
               N. Radical sublobar resection for small-sized non-small cell lung   NSCLC treated with stereotactic body radiotherapy versus surgical
               cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-  resection. Anticancer Res 2015;35:5607-14.
               75.                                            53.  Rosen JE, Salazar  MC, Wang  Z, Yu JB, Decker  RH, Kim  AW,
           40.  Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto   Detterbeck  FC, Boffa DJ. Lobectomy versus stereotactic  body
               M, Nagai K, Tada H, Mitsudomi T, Tsuboi M, Shibata T, Fukuda H;   radiotherapy in healthy patients with stage I lung cancer. J Thorac
               Japan Clinical Oncology Group Lung Cancer Surgical Study Group.   Cardiovasc Surg 2016;152:44-54.
               Radiographically  determined  noninvasive adenocarcinoma  of the   54.  Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA,
               lung: survival outcomes of Japan Clinical Oncology Group 0201. J   Wisnivesky JP. Outcomes after stereotactic body radiotherapy versus
               Thorac Cardiovasc Surg 2013;146:24-30.            limited  resection in older patients  with early-stage  lung cancer.  J
           41.  Moon Y, Lee KY, Moon SW, Park JK. Sublobar resection margin   Thorac Oncol 2015;10:1201-6.
               width does not affect recurrence of clinical N0 non-small cell lung   55.  Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus
               cancer presenting as GGO-predominant nodule of 3 cm or less. World   limited resection for T1 N0 non-small cell lung cancer. Lung Cancer
               J Surg 2017;41:472-9.                             Study Group. Ann Thorac Surg 1995;60:615-22.
           42.  Sirzén  F, Kjellén  E,  Sörenson S, Cavallin-Ståhl  E.  A systematic   56.  Nakamura  K, Saji  H, Nakajima  R, Okada  M, Asamura  H, Shibata
               overview of radiation therapy effects in non-small cell lung cancer.   T, Nakamura S, Tada H, Tsuboi M. A phase III randomized trial of
               Acta Oncol 2003;42:493-515.                       lobectomy  versus limited  resection  for small-sized  peripheral  non-
           43.  Onishi H, Araki T, Shirato H, Nagata  Y, Hiraoka M, Gomi K,   small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol
               Yamashita T, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura   2010;40:271-4.
               T, Hirokawa Y, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara   57.  Suzuki K, Watanabe S, Mizusawa J, Moriya Y, Yoshino I, Tsuboi M,
               R,  Itami  J, Yamada  K. Stereotactic  hypofractionated  high-dose   Mizutani T, Nakamura K, Tada H, Asamura H; Japan Lung Cancer
               irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes   Surgical Study Group (JCOG LCSSG). Predictors of non-neoplastic
               in 245 subjects in a Japanese multiinstitutional  study.  Cancer   lesions in lung tumours showing ground-glass opacity on thin-section
               2004;101:1623-31.                                 computed  tomography based on a multi-institutional  prospective
           44.  Davis JN, Medbery C 3rd, Sharma S, Perry D, Pablo J, D’Ambrosio   study†. Interact Cardiovasc Thorac Surg 2015;21:218-23.
               DJ, McKellar H, Kimsey FC, Chomiak PN, Mahadevan A. Stereotactic   58.  Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M, Suzuki
               body radiotherapy for early-stage non-small cell lung cancer: clinical   K, Watanabe S, Asamura H. Limited resection for early-stage non-
               outcomes from a National Patient Registry. J Radiat Oncol 2015;4:55-  small cell lung cancer as function-preserving radical  surgery: a
               63.                                               review. Jpn J Clin Oncol 2017;47:7-11.
           45.  Shibamoto Y, Hashizume C, Baba F, Ayakawa S, Miyakawa A, Murai   59.  NCT00499330. Phase III randomized  study of lobectomy  versus
               T, Takaoka T, Hattori Y, Asai R. Stereotactic body radiotherapy using   sublobar resection in patients with small peripheral stage IA non-small
               a radiobiology-based regimen for stage I non-small-cell lung cancer:   cell lung cancer. Available from: https://www.georgiacancerinfo.org/
               five-year mature results. J Thorac Oncol 2015;10:960-4.  clinical-trials/lung-cancer/2591. [Last accessed on 28 Mar 2017].
           46.  Hamaji  M, Chen  F, Matsuo Y, Kawaguchi  A, Morita  S, Ueki   60.  Fernando HC, Landreneau RJ, Mandrekar SJ, Nichols FC, Hillman
               N, Sonobe  M, Nagata  Y, Hiraoka  M, Date  H. Video-assisted   SL, Heron DE, Meyers BF, DiPetrillo TA, Jones  DR,  Starnes SL,
               thoracoscopic lobectomy versus stereotactic radiotherapy for stage I   Tan AD, Daly BD, Putnam JB Jr. Impact of brachytherapy on local
               lung cancer. Ann Thorac Surg 2015;99:1122-9.      recurrence  rates after sublobar resection:  results from ACOSOG
           47.  Bhandari RP, Stanford JD, Packianathan  S, Duggar WN,   Z4032 (Alliance), a phase III randomized trial for high-risk operable
               Kanakamedala  MR, Zhang  X, Giri  SP, Kumar  PP, Harrell  LM,   non-small-cell lung cancer. J Clin Oncol 2014;32:2456-62.
               Mangana SH, Yang C, Vijayakumar S. Stereotactic body radiation   61.  Takahashi  N, Sawabata  N, Kawamura  M, Ohtsuka T,  Horio
               therapy for stage I non-small cell lung cancer: a retrospective, single-  H, Sakaguchi  H, Nakayama  M, Yoshiya K, Chida  M, Hoshi E.
               center study of 55 patients. Oncology 2016;91:194-204.  Multicenter  prospective  study of sublobar  resection  for c-stage  I
           48.  Lischalk JW, Woo SM, Kataria S, Aghdam N, Paydar I, Repka MC,   non-small  cell  lung cancer  patients  unable  to undergo lobectomy
               Anderson ED, Collins BT. Long-term outcomes of stereotactic body   (KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg
               radiation therapy (SBRT) with fiducial tracking for inoperable stage I   2016;64:470-5.
               non-small cell lung cancer (NSCLC). J Radiat Oncol 2016;5:379-87.  62.  Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J,
           49.  Puri V, Crabtree TD, Bell  JM, Broderick  SR, Morgensztern D,   Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy
               Colditz  GA, Kreisel D, Krupnick AS, Patterson GA, Meyers BF,   H. Stereotactic body radiation therapy for inoperable early stage lung
               Patel A, Robinson CG. Treatment outcomes in stage I lung cancer:   cancer. JAMA 2010;303:1070-6.
               a comparison of surgery and stereotactic  body radiation therapy.  J   63.  Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K,
               Thorac Oncol 2015;10:1776-84.                     Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa
           50.  Ricardi U, Frezza G, Filippi AR, Badellino S, Levis M, Navarria P,   K, Hareyama  M, Takai  Y, Hayakawa  K, Mitsuhashi  N, Ishikura
               Salvi F, Marcenaro M, Trovò M, Guarneri A, Corvò R, Scorsetti M.   S. Prospective  trial  of stereotactic  body radiation  therapy  for both
               Stereotactic  ablative radiotherapy  for stage I histologically  proven   operable and inoperable T1N0M0 non-small cell lung cancer: Japan
             22                                                                                                       Mini-invasive Surgery ¦ Volume 1 ¦ March 31, 2017
   24   25   26   27   28   29   30   31   32   33   34